InvestorsHub Logo
icon url

Zadie420

12/24/23 1:58 PM

#658933 RE: flipper44 #658930

Flipper44- what do u see the milestones (events) for NWBO in six months into 2024? Tia
icon url

AngeloFoca

12/24/23 3:18 PM

#658946 RE: flipper44 #658930

I hate it when articles don't include a release date !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!



.
icon url

exwannabe

12/26/23 8:48 AM

#659136 RE: flipper44 #658930

Gee, thanks for letting me know that trial exists and uses Oncovir;s Poly-ICLC.

Now, can you please explain how that supports the absurd statements made by dstock?

Per dstock (and now you, dd and others):

Poly-iclc has meaning only in combination with DCVax-L.



So all the other trials of Poly-iCLC are meaningless. Odd that Oncovir lists many of these meaningless P2./3 trials on their website and never mentions UCLA trial. Maybe they do not consider that their only reason to exist?

Oncovir must disclose the information about the efficacy of poly-iclc combined with DCVax-L which involves the confidential information concerning the third party, in this case, it is NWBO


Why must Oncovir disclose this? Is there some weird law about that?

The idea presented by dstock and supported by at elast a half doze longs that Oncovir is all about DCVax-L is total nonsense. They are a company that is raunnign a broad spectrum of trials with many partners,

But keep those blinders on.